By Counterforce Health Team in Firdapse (amifampridine) —

Getting Firdapse (Amifampridine) Covered by Humana in Florida: PA Requirements, Appeals Timeline, and Cost Support

Quick Answer: Humana requires prior authorization for Firdapse (amifampridine) to treat Lambert-Eaton myasthenic syndrome (LEMS). You'll need confirmed LEMS diagnosis via antibody testing and EMG, neuromuscular specialist documentation, and evidence of medical necessity. If denied, file a redetermination appeal within 65 days. Start today: Call Humana member services to verify PA requirements and download the redetermination form.

Table of Contents

Policy Overview

Humana covers Firdapse (amifampridine) under its Medicare Advantage and Part D plans for patients with Lambert-Eaton myasthenic syndrome (LEMS), but prior authorization is required for all requests. The medication is typically placed on specialty tier (Tier 4 or 5) with 25-50% coinsurance rather than a fixed copay.

Humana's PA policies align with CMS guidelines and are effective through at least January 1, 2026. The insurer has one of the lowest PA denial rates among major Medicare plans at approximately 3.5%, but denials that do occur often involve documentation gaps or formulary placement issues.

Plan Types Covered

  • Medicare Advantage (Part C)
  • Medicare Part D prescription drug plans
  • Some commercial and marketplace plans (verify specific policy)

Coverage Requirements

Coverage at a Glance

Requirement Details Documentation Needed Source
Diagnosis Confirmed LEMS in patients ≥6 years Anti-P/Q VGCC antibodies, EMG with >100% increment FDA Label
Prescriber Neuromuscular specialist preferred DEA number, specialty credentials Humana PA Guidelines
Step Therapy Often required Prior therapy failures documented Plan-specific
Quantity Limits Up to 100mg daily (adults ≥45kg) Dosing rationale in medical records Updated FDA Dosing
Appeals Deadline 65 days from denial notice Redetermination form required CMS Guidelines

Step Therapy and Exceptions

Humana typically requires documentation of trials with alternative therapies before approving Firdapse, unless contraindications exist. Common step therapy requirements include:

Required Prior Treatments

  1. Pyridostigmine (cholinesterase inhibitor)
  2. Immunosuppressive therapy (corticosteroids, azathioprine)
  3. Supportive care optimization

Medical Exception Pathways

You can bypass step therapy requirements if you document:

  • Contraindications to required medications
  • Previous treatment failures (include dates, doses, duration)
  • Intolerance or adverse reactions to alternative therapies
  • Clinical urgency requiring immediate Firdapse initiation
Tip: Include specific details about why alternatives failed, such as inadequate symptom control despite optimal dosing or documented adverse effects requiring discontinuation.

Quantity Limits and Dosing

FDA-Approved Maximum Doses

  • Adults and pediatric ≥45kg: Up to 100mg daily (updated from 80mg in 2023)
  • Pediatric <45kg: Up to 40mg daily
  • Maximum single dose: 20mg (adults), 10mg (pediatric <45kg)

Humana Quantity Limits

Many Humana plans may still have quantity limits set at the previous 80mg daily maximum. If your prescription exceeds this amount, expect a prior authorization review requiring:

  • Documentation of inadequate response at lower doses
  • Confirmation of patient weight ≥45kg for doses >40mg daily
  • Clinical justification for doses between 80-100mg daily

For prescribers: Reference the updated FDA maximum of 100mg daily in your PA request if prescribing above 80mg.

Required Diagnostics

LEMS Diagnostic Confirmation

Humana requires definitive LEMS diagnosis through:

Antibody Testing

  • Anti-P/Q type voltage-gated calcium channel (VGCC) antibodies
  • Positive threshold: >30 pmol/L (0.03 nmol/L)
  • Sensitivity: ~85-90% (negative results don't rule out LEMS)

Electrodiagnostic Studies

  • Low compound muscle action potential (CMAP) amplitudes at rest
  • ≥100% increment with high-frequency repetitive nerve stimulation or post-exercise facilitation
  • Performed by neuromuscular specialist with EMG expertise

Clinical Documentation

  • Proximal muscle weakness (especially lower extremities)
  • Autonomic symptoms (dry mouth, constipation)
  • Reduced/absent deep tendon reflexes with post-exercise facilitation

Documentation Timeline

  • Lab results should be recent (typically within 6-12 months)
  • EMG studies within 12 months unless clinical status unchanged
  • Ongoing neuromuscular specialist follow-up required

Site of Care Requirements

Firdapse is an oral medication dispensed through specialty pharmacies for most Humana plans. Key requirements:

Specialty Pharmacy Network

  • Must use Humana's contracted specialty pharmacy providers
  • Cannot be filled at regular retail pharmacies
  • Prior authorization must be approved before specialty pharmacy dispensing

Monitoring Requirements

  • Regular neuromuscular specialist visits (typically every 3-6 months)
  • Periodic assessment of treatment response
  • Monitoring for contraindications (seizures, cardiac issues)

Appeals Process in Florida

If Humana denies your Firdapse request, you have specific appeal rights under Medicare and Florida law.

Timeline and Deadlines

  • File appeal within: 65 calendar days from denial notice (increased from 60 days in 2025)
  • Standard decision: 7 calendar days
  • Expedited decision: 24 hours (if health risk is imminent)

How to File an Appeal

Step 1: Gather Documentation

  • Original denial letter
  • Prescription and medical records
  • Prescriber letter addressing denial reasons
  • Clinical evidence supporting medical necessity

Step 2: Submit Redetermination Request

  • Online: Humana member portal
  • Phone: 800-867-6601 (or number on your member ID card)
  • Mail/Fax: Use Humana's redetermination form (verify current link)

Step 3: Request Expedited Review if Urgent Check the "expedited" box on your form if waiting for standard review could seriously jeopardize your health or ability to regain maximum function.

External Review Options

If Humana denies your internal appeal, you can escalate to an Independent Review Entity (IRE) within 60 days. Florida follows federal Medicare appeal processes rather than state-specific external review for Medicare plans.

For assistance: Contact Florida's Insurance Consumer Helpline at 877-693-5236 or Medicare SHIP counseling at 800-633-4227.

Cost Support Options

Manufacturer Assistance

Catalyst Pathways Program

  • Phone: 833-422-8259
  • Website: YourCatalystPathways.com
  • Provides copay assistance and patient support services
  • May cover significant portion of out-of-pocket costs for eligible patients

Additional Support

  • Medicare Extra Help: Low-income subsidy program for Part D costs
  • State pharmaceutical assistance programs: Limited availability in Florida
  • Patient advocacy organizations: LEMS-specific support groups may provide resources
From our advocates: We've seen cases where patients initially faced $1,000+ monthly copays get their costs reduced to under $50 through a combination of manufacturer assistance and Medicare Extra Help programs. The key is applying for all available programs simultaneously rather than trying them one at a time.

Common Denial Reasons

Denial Reason How to Overturn Required Documentation
Insufficient LEMS diagnosis Provide complete diagnostic workup VGCC antibodies, EMG with increment data, specialist notes
Step therapy not completed Document contraindications or failures Prior therapy records, adverse event documentation
Exceeds quantity limits Reference updated FDA dosing Clinical justification for doses >80mg daily
Not medically necessary Comprehensive medical necessity letter Functional assessments, treatment goals, guideline citations
Missing specialist oversight Neuromuscular consultation Specialist evaluation and ongoing care plan

FAQ

How long does Humana prior authorization take for Firdapse? Standard PA decisions are issued within 72 hours of receiving complete documentation. Expedited reviews are completed within 24 hours if clinical urgency is demonstrated.

What if Firdapse is non-formulary on my plan? You can request a formulary exception by demonstrating medical necessity and that preferred alternatives are inappropriate. This requires additional documentation but follows the same appeal process.

Can I get an expedited appeal in Florida? Yes, if waiting for a standard review could seriously jeopardize your health. Submit your appeal with supporting medical documentation explaining the urgency.

Does step therapy apply if I tried alternatives in another state? Yes, prior therapy documentation from other states is generally accepted. Ensure you have complete records including dates, doses, and outcomes.

What happens if my appeal is denied? You can escalate to an Independent Review Entity (IRE) within 60 days. This external review is binding on Humana if decided in your favor.

Are there age restrictions for Firdapse coverage? Humana covers Firdapse for patients ≥6 years old with confirmed LEMS, matching FDA approval. Pediatric dosing limits apply for patients <45kg.

Getting help with complex prior authorizations and appeals can be overwhelming, especially when dealing with rare conditions like LEMS. Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters and crafting point-by-point rebuttals aligned to each plan's specific requirements.

Important Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and change frequently. Always verify current requirements with your specific Humana plan and consult your healthcare provider for medical decisions. For official Florida insurance assistance, contact the Department of Financial Services Consumer Helpline at 877-693-5236.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.